A predictive risk model for outcomes of ischemic stroke

Stroke

Volumn 31, Issue 2, 2000, Pages 448-455

  Johnston, Karen ^a,b,c   Connors Jr , A F ^b   Wagner, D P ^b   Knaus, W A ^b   Wang, X Q ^b   Haley Jr , E Clarke ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Models; Prognosis; Statistical; Stroke outcome; Stroke, ischemic

Indexed keywords

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; HEART INFARCTION SIZE; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 0033950258     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.31.2.448     Document Type: Article

References (47)

1. Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shulka R. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998;29:415-421.
2. Kotila M, Waltimo O, Neimi ML, Laaksonen MA, Lempinen M. The profile of recovery from stroke and factors influencing outcome. Stroke. 1984;15:1039-1044.
3. Dove HG, Schneider KC, Wallace JD. Evaluating and predicting outcome of acute cerebral vascular accident. Stroke. 1984;15:858-864.
4. Allen CMC. Predicting the outcome of acute stroke: a prognostic score. J Neurol Nearosurg Psychiatry. 1984;47:475-480.
5. Wade DT, Wood VA, Hewer RL. Recovery after stroke: the first 3 months. J Neurol Neurosurg Psychiatry. 1985;48:7-13.
6. Jongbloed L. Prediction of function after stroke: a critical review. Stroke. 1986;17:765-776.
7. Chambers BR, Morris JW, Shurvell BL, Hachinski VC. Prognosis of acute stroke. Neurology. 1987;37:221-225.
8. Sacco SE, Whisnam JP, Broderick JP, Phillips SJ, O'Fallon M. Epidemiological characteristics of lacunar infarcts in a population. Stroke. 1991;22:1236-1241.
9. Lefkovits J, Davis SM, Rossiter SC, Kilpatrick CJ, Hopper JL, Green R, Tress BM. Acute stroke outcome: effects of stroke type and risk factors. Aust N Z J Med. 1992;22:30-35.
10. Censori B, Camerlingo M, Casto L, Ferraro B, Gazzaniga GC, Cesana B, Mamoli A. Prognostic factors in first-ever stroke in the carotid artery territory seen within 6 hours after onset. Stroke. 1993;24:532-535.
11. Fiorelli M, Alpérovitch A, Argentino C, Sacchetti ML, Toni D, Sette G, Cavalletti C, Gori MC, Fieschi C, for the Italian Acute Stroke Study Group. Prediction of long-term outcome in the early hours following acute ischemic stroke. Arch Neurol. 1995;52:250-255.
12. The NINDS t-PA Stroke Study Group. Generalized efficacy of t-PA for acute stroke: subgroup analysis of the NINDS t-PA Stroke Trial. Stroke. 1997;28:2119-2125.
13. DeGraba TJ, Hallenbeck JM, Pettigrew KD, Dutka AJ, Kelly BJ. Progression in acute stroke value of the initial NIH Stroke Scale score on patient stratification in future trials. Stroke. 1999;30:1208-1212.
14. Brott T, Marler JK, Olinger CP, Adams HP, Tomsick T, Barsan WG, Biller J, Eberle R, Hertzberg V, Walker M. Measurements of acute cerebral infarction: lesion size by computed tomography. Stroke. 1989; 20:871-875.
15. Saver JL, Johnston KC, Homer D, Wityk R, Koroshetz W, Truskowski LL, Haley EC, for the RANTTAS Investigators. Infarct volume as a surrogate or auxiliary outcome measure in ischemic stroke clinical trials. Stroke. 1999;30:293-298.
16. Bonita R, Ford MA, Stewart AW. Predicting survival after stroke: a three-year follow-up. Stroke. 1988;19:669-673.
17. Hénon H, Godefroy O, Leys D, Mounier-Vehier F, Lucas C, Rondepierre P, Duhamel A, Pruvo JP. Early predictor of death and disability after acute cerebral ischemic event. Stroke. 1995;26:392-398.
18. Toni D, Fiorelli M, Bastianello S, Falcou A, Sette G, Ceschin V, Sacchetti ML, Argentino C. Acute ischemic strokes improving during the first 48 hours of onset: predictability, outcome, and possible mechanisms: a comparison with early deteriorating strokes. Stroke. 1997;22:10-14.
19. Finocchi C, Gandolfo C, Gasparetto B, Del Sette M, Croce R, Loeb C. Value of early variables as predictors of short-term outcome in patients with acute focal cerebral ischemia. Ital J Neural Sci. 1996;17:341-346.
20. The RANTTAS Investigators. A Randomized Trial of Tirilazad Mesylate in Patients With Acute Stroke (RANTTAS). Stroke. 1996;27:1453-1458.
21. Harrell FE, Lee KL, Mark DB. Tutorial in biostatistics: multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15: 367-387.
22. Lyden P, Brott T, Tilley B, Welch KM, Mascha EJ, Levine S, Haley EC, Grotta J, Marler J, for the NINDS TPA Stroke Study Group. Improved reliability of the NIH Stroke Scale using video training. Stroke. 1994;25: 2220-2226.
23. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
24. Madden KP, Karanjia PN, Adams HP Jr, Clarke WR. Accuracy of initial stroke subtype diagnosis in the TOAST study: Trial of ORG 10172 in Acute Stroke Treatment. Neurology. 1995;45:1975-1979.
25. Mahoney FT, Barthel DW. Functional evaluation: Barthel Index. Md Med J. 1965;14:61-65.
26. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med. 1995;333:1581-1587.
27. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29-36.
28. Buse A. The likelihood ratio, Wald, and Lagrance multiplier tests: an expository note. Am Stat. 1982;36:153-157.
29. Efron B, Gong G. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat. 1983;37:36-18.
30. Warach S, Gaa J, Stewert B, Wielopolski P, Edelman RR. Acute human stroke studied by whole brain echo planar diffusion-weighted magnetic resonance imaging. Ann Neurol. 1995;37:231-241.
31. Gonzalez G, Schaefer P, Buonanno F, Schwamm L, Budzik R, Rordorf G, Wang B, Sorensen G, Koroshetz W. Clinical sensitivity and specificity of diffusion weighted MRI in hyperacute stroke. Stroke. 1997;28:243. Abstract.
32. Singer MB, Chong J, Lu D, Schonewille WJ, Tuhrim S, Atlas S. Diffusion-weighted MRI in acute subcortical infarction. Stroke. 1998;29: 133-136.
33. Baird, AE, Benfield A, Schlaug G, Siwert B, Lovblad KO, Edelman RR, Warach S. Enlargement of human cerebral ischemic lesion volumes measured by diffusion-weighted magnetic resonance imaging. Ann Neurol. 1997;41:581-589.
34. Lee LJ, Kidwell C, Alger J, Starkman S, Saver JL. Impact upon stroke subtype diagnosis of early diffusion-weighted MR and MRA imaging. Neurology. 1998;50:A298. Abstract.
35. Fisher M, Albers GW. Applications of diffusion-perfusion magnetic resonance imaging in acute ischemic stroke. Neurology. 1999;52: 1750-1756.
36. Fisher M, Takano K. The penumbra, therapeutic time window and acute ischaemic stroke. Baillieres Clin Neurol. 1995;4:279-295.
37. Lang EW, Daffertshofer M, Daffertshofer A, Wirth SB, Chesnut RM, Hennerici M. Variability of vascular territory in stroke: pitfalls and failure of stroke pattern interpretation. Stroke. 1995;26:942-945.
38. Rosenthal GE, Shah A, Way LE, Harper DL. Variations in standardized hospital mortality rates for six common medical diagnoses: implications for profiling hospital quality. Med Care. 1998;36:955-964.
39. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet. 1997;350: 607-614.
40. Kwakkel G, Wagenaar RC, Koelman TW, Lankhorst GJ, Joetsier JC. Effects of intensity of rehabilitation after stroke: a research synthesis. Stroke. 1997;28:1550-1556.
41. Kwakkel G, Wagenaar RC, Kollen BJ, Lankhorst GJ. Predicting disability in stroke: a critical review of the literature. Age Ageing. 1996;25: 479-489.
42. Orteils ML, Mostacero E. Clinical pathogenic heterogeneity and subcortical infarcts prognosis. Rev Neurol. 1996;24:179-182.
43. Rothwell PM. Can overall results of clinical trials be applied to all patients? Lancet. 1995;345:1616-1619.
44. Del Zoppo GJ. Why do all drugs work in animals but none in stroke patients? I: drugs promoting cerebral blood flow. J Intern Med. 1995; 273:79-88.
45. Grotta J. Why do all drugs work in animals but none in stroke patients? II: neuroprotective therapy. J Intern Med. 1995;237:89-94.
46. Bath P. Alteplase not yet proven for acute ischaemic stroke. Lancet. 1998;352:1238-1239.
47. Knaus WA, Harrell FE Jr, LaBrecque JF, Wagner DP, Pribble JP, Draper EA, Fisher CJ Jr, Soil L. Use of predicted risk of mortality to evaluate the efficacy of anticytokine therapy in sepsis. Crit Care Med. 1996;24: 46-56.